Movicol Junior Aromafrei

Macrogol 3350, the active ingredient in Movicol Junior Aromafrei, is an osmotic laxative presented as a oral solution for oral use. It treats constipation in children and adolescents.

GNH USA supplies Movicol Junior Aromafrei as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Movicol Junior Aromafrei, an osmotic laxative, is used to manage constipation in the pediatric population.

Constipation in children: softens stool and facilitates regular bowel movements. Functional constipation: improves stool frequency and consistency. Chronic constipation: provides long‑term relief when dietary measures are insufficient.

Movicol Junior Aromafrei may cause a range of adverse reactions. Patients should be aware of both frequent and less common events.

Common Side Effects: - Abdominal bloating - Flatulence - Nausea - Abdominal pain - Diarrhoea - Increased thirst

Serious or Rare Side Effects: - Severe electrolyte imbalance (e.g., hyponatraemia) - Marked dehydration - Allergic reaction (rash, urticaria, angio‑edema) - Severe abdominal pain - Blood in stool or rectal bleeding - Acute renal impairment

Before using Movicol Junior Aromafrei, consider the following safety measures. - Assess hydration status: ensure the patient is adequately hydrated before initiating therapy. - Monitor electrolytes: check serum sodium, potassium and chloride especially with prolonged use. - Use under medical supervision: pediatric patients should be evaluated by a healthcare professional. - Avoid in intestinal obstruction: contraindicated in cases of mechanical blockage. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Movicol Junior Aromafrei can interact with other medicines; some combinations require avoidance while others need monitoring.

Major Interactions (Avoid): - Concurrent strong laxatives: may cause severe electrolyte loss. - Co‑administration with diuretics: can exacerbate dehydration.

Moderate Interactions (Monitor Closely): - Oral rehydration solutions: may affect electrolyte balance. - Anticholinergic agents: may reduce the laxative effect. - Certain antibiotics (e.g., tetracyclines): may alter gut flora and affect drug absorption.